Hrabyne, Czechia

Josef Stuchlik


Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Josef Stuchlik

Introduction

Josef Stuchlik is a notable inventor based in Hrabyne, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug delivery and bioavailability. With a total of 3 patents to his name, Stuchlik's work is recognized for its potential impact on therapeutic treatments.

Latest Patents

One of his latest patents includes an immunomodulatory pharmaceutical composition designed to form lyotropic liquid crystals when in contact with an aqueous phase. This formulation is particularly focused on cyclosporin, providing therapeutic compositions that ensure high bioavailability of active ingredients. The innovative approach allows for concentrations in dosage forms that exceed 10%, which is a significant advancement in pharmaceutical formulations.

Career Highlights

Stuchlik's career is marked by his dedication to research and development in the pharmaceutical industry. He is currently associated with Galena AS, where he continues to explore new avenues for enhancing drug efficacy and patient outcomes. His work has garnered attention for its scientific rigor and practical applications in medicine.

Collaborations

Throughout his career, Josef Stuchlik has collaborated with various professionals in the field. Notable coworkers include Milan Stuchlik and Vladimir Matha, who have contributed to his research endeavors and the development of innovative pharmaceutical solutions.

Conclusion

Josef Stuchlik's contributions to the field of pharmaceuticals through his patents and innovative formulations highlight his role as a significant inventor. His work continues to pave the way for advancements in drug delivery systems, ultimately benefiting patient care and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…